Kidney Cancer Trial, Recruiting NCT07020169 Sponsor: Shao Pengfei Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT07020169
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 80 years, of any gender
  • People who have given written consent to participate, either personally or through a legally authorised representative, after being fully informed about the trial
  • People whose pre-surgery scans (CT or MRI) have confirmed a small kidney tumour at an early stage that is considered suitable for surgery to remove only part of the kidney, based on a standard scoring system used by doctors to assess the tumour (confirm with trial site)
  • People whose kidney tumour is confined to the kidney, with no spread to nearby lymph nodes or other parts of the body, according to established medical guidelines
  • People who are scheduled to have a planned, minimally invasive kidney-sparing surgery (using either laparoscopic or robotic techniques) following thorough surgical discussion

Who may not be able to join:

  • People who have more than one kidney tumour, whether in one kidney or both kidneys
  • People who have received cancer treatments such as targeted therapy, immunotherapy, or chemotherapy within the past 6 months
  • People who have medical conditions that make surgery unsafe, such as very high surgical risk or uncontrolled blood clotting problems (confirm with trial site)
  • People whose surgery needed to be changed during the operation to remove the whole kidney, or required open surgery instead of minimally invasive surgery
  • People who require additional cancer treatment in the 12 months after surgery, during the trial's follow-up period
  • People with serious ongoing health conditions, such as severe heart failure or significantly reduced kidney function, that could affect how results are measured (confirm with trial site)
  • People who are already taking part in another interventional clinical trial
  • People whom the trial doctors determine are not suitable after weighing the potential risks and benefits

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613851925825

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shao Pengfei
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Operative Time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov